NASEM Forum on Aging, Disability, and Independence
|
Committee, Work group, Advisory group, or Task Force
|
ACL
|
NIA
|
The National Academies of Sciences, Engineering, and Medicine have formed the Forum on Aging, Disability, and Independence to foster dialogue and address issues of mutual interest and concern related to aging and disability.
|
NASEM Forum on Drug Discovery, Development, and Translation
|
Committee, Work group, Advisory group, or Task Force
|
ASPR, FDA
|
NCATS, NCI, NIAID, NIMH, NINDS, OD/OSP
|
The Forum on Drug Discovery, Development, and Translation provides a neutral venue for stakeholders in government, academia, industry – including pharmaceutical, biotechnology, and digital health companies, foundations, and disease and patient advocacy to highlight critical issues, spur cross-sector collaboration, and inspire action towards improving the system of drug discovery, development, and translation. Forum-hosted public workshops, action collaboratives, and meetings focus on critical issues and practical approaches for advancing a clinical trials enterprise that is more efficient, effective, patient-centered, and integrated into the health delivery system.
|
NASEM Forum on Neuroscience and Nervous System Disorders
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCCIH, NIA, NIAAA, NIDA, NIEHS, NIMH, NINDS
|
The National Academies of Sciences, Engineering, and Medicine (NASEM) Forum on Neuroscience and Nervous System Disorders was established to bring together leaders from government, industry, academia, and disease advocacy organizations to examine issues concerning scientific needs and policies related to neuroscience and nervous system disorders research and the development and use of interventions for the nervous system. The Forum also sponsors workshops for its members and the public on key challenges and issues in the field.
|
NASEM Forum on Traumatic Brain Injury
|
Committee, Work group, Advisory group, or Task Force
|
ACL, CDC
|
NIA, NICHD, NINDS
|
The National Academies of Sciences, Engineering, and Medicine (NASEM) Forum on Traumatic Brain Injury provides a setting for experts to discuss how to advance the prevention, treatment, and care for people with brain injuries. The TBI Forum addresses topics relating to critical research gaps, TBI treatment and rehabilitation, and other related needs and challenges.
|
NASEM Foundations for Digital Twins Consensus Study
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
NCI, NIBIB, NLM, OD/DPCPSI/ODSS
|
Identify needs and opportunities to advance the mathematical, statistical, and computational foundations of digital twins in applications across science, medicine, engineering, and society.
|
NASEM Roundtable on Genomics and Precision Health
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
NCI, NHGRI, NIA, NIMH
|
This roundtable brings together diverse voices to encourage innovation and actions that foster the wide adoption of and equitable access to the benefits of genomics and precision health.
|
NASEM Roundtable on Obesity Solutions
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIDDK
|
This Working Group includes representatives from the NIH, CDC, Academia, NGOs, and Industry.
|
National Academy of Medicine Committee on Emerging Science, Technology, and Innovation in Health and Medicine
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIMH
|
The National Academy of Medicine has recently launched a new Committee on Emerging Science, Technology, and Innovation in health and medicine. The Committee will bring together experts in diverse fields to assess the landscape of emerging scientific advances and technologies in health and medicine and address the potential societal, ethical, legal, and workforce implications of such technologies. The goal of the Committee is to develop a multi-sectoral governance policy framework. The Committee plans to examine examples of emerging technologies and their implications for society, through a multi-sectoral lens. The first point of focus will be on neurotechnology, specifically transcranial direct current stimulation.
|
National Action Alliance for Suicide Prevention (NAASP)
|
Committee, Work group, Advisory group, or Task Force
|
ACL, CDC, HRSA, IHS, OS, OSG, SAMHSA
|
NIAAA, NIDA, NIMH, OD/DPCPSI/OBSSR
|
Founded in September 2010, the National Action Alliance for Suicide Prevention (NAASP) is a public-private partnership designed to advance the National Strategy for Suicide Prevention in the United States. The NAASP's Research Prioritization Task Force (RPTF) was charged with developing a process to prioritize suicide prevention research efforts and consider ways to integrate science and service to ensure that suicide deaths decrease significantly within the next decade. The RPTF released the Nation's first suicide research agenda, A Prioritized Research Agenda for Suicide Prevention: An Action Plan to Save Lives. The research agenda includes an overarching goal to advance suicide prevention research more rapidly, seeking ways to reduce suicide deaths and attempts by 20 percent in five years and by 40 percent or greater in ten years. In 2015, the RPTF produced the "U.S. National Suicide Prevention Research Efforts: 2008-2013 Portfolio Analyses." The analyses revealed that investments in suicide research are severely lagging, but there is a growing knowledge base of intervention research. NIMH participates in a number of NAASP activities related to identifying research needs for improving risk identification and suicide preventive care within healthcare systems, justice, and school settings.
|
National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) 2020-2025
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, BARDA, CDC, CMS, FDA
|
NIAID
|
The National Action Plan for Combating Antibiotic-resistant Bacteria, 2020-2025, was developed through the CARB Task Force, now reporting coordinated, strategic actions that the U.S. government takes to reduce the impact of antibiotic and antimicrobial resistance on the nation.
|